Financial release accessible
online
BOSTON, May 11, 2023
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that
financial results for its fourth quarter fiscal 2023, which ended
April 1, 2023, are available on its
Investor Relations website.
The Company will host a conference call and webcast with
investors and analysts to discuss and answer questions about the
results at 8:00 a.m. ET on
May 11, 2023. The conference call and
webcast can be accessed with the following information:
- Teleconference link:
https://register.vevent.com/register/BI23e57bd41a0f40cc9ef2f258cb4ac3e7
- Once registration is completed, participants will receive a
dial-in number along with a personalized PIN to access the call.
While not required, it is recommended that participants join 10
minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics'
investor relations website or via the following link:
https://edge.media-server.com/mmc/p/wm7hxoqy
In addition, the Company has posted to its Investor Relations
website the earnings release and analytical tables and supplemental
information that will be referenced on its conference call and
webcast, direct links to which are available below.
Direct link to 4Q FY23 Earnings Release:
https://haemonetics.gcs-web.com/static-files/926b0cd9-052d-4f8b-8ea9-1d55bfae4a3c
Direct link to 4Q FY23 Analytical Tables and Supplemental
Information:
https://haemonetics.gcs-web.com/static-files/c556d6b4-2a16-49c2-a7e1-357cb54fa404
A replay of the conference call and webcast will be available
for one year beginning on May 11,
2023, at 11:00 a.m. ET using
the conference call webcast link provided in this press
release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global
healthcare company dedicated to providing a suite of innovative
medical products and solutions for customers, to help them improve
patient care and reduce the cost of healthcare. Our technology
addresses important medical markets: blood and plasma component
collection, the surgical suite and hospital transfusion services.
To learn more about Haemonetics, visit www.haemonetics.com.
|
|
Investor
Contacts:
|
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
|
(781)
356-9763
|
(203)
733-4987
|
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
|
Media
Contact:
|
|
|
Josh Gitelson,
Director-Global Communications
|
|
|
(781)
356-9776
|
|
|
josh.gitelson@haemonetics.com
|
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-4th-quarter-fiscal-year-2023-earnings-release-available-on-investor-relations-website-301821878.html
SOURCE Haemonetics Corporation